Major trial tests new pill for dialysis Patients' anemia
NCT ID NCT06520826
Summary
This study is testing the safety of an oral medication called vadadustat for treating anemia in people receiving dialysis for kidney failure. It involves 2,200 adult patients who receive dialysis three times weekly and compares the new pill to standard anemia treatments. The main goal is to see if the medication affects hospitalizations and survival rates over the long term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA OF CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dallas Renal Group
Dallas, Texas, 75230, United States
-
Nephrology and Hypertension Specialists, PC
Dalton, Georgia, 30720, United States
-
US Renal Care - Gallup
Gallup, New Mexico, 87301, United States
-
US Renal Care - Live Oak
Live Oak, Texas, 78233, United States
-
USRC Kidney Research
Lone Tree, Colorado, 80124, United States
Conditions
Explore the condition pages connected to this study.